Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

This study has been completed.
Sponsor:
Collaborators:
Schering-Plough
Eisai Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00791271
First received: November 12, 2008
Last updated: November 12, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2015
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)